NIH Funds Community Engagement Research Efforts in Areas Hardest Hit by COVID-19

The National Institutes of Health today announced a $12 million award for outreach and engagement efforts in ethnic and racial minority communities disproportionately affected by the COVID-19 pandemic. The award to RTI International, a non-profit research institution, will support teams in 11 states established as part of the NIH Community Engagement Alliance (CEAL) Against COVID-19 Disparities.… Read full story

NIH Awards Contracts to Develop Innovative Digital Health Technologies for COVID-19

The National Institutes of Health has awarded seven contracts to companies and academic institutions to develop digital health solutions that help address the COVID-19 pandemic. The work could lead to user-friendly tools such as smartphone apps, wearable devices, and software that can identify and trace contacts of infected individuals, keep track of verified COVID-19 test results, and monitor the health status of infected and potentially infected individuals.… Read full story

Vaping, Marijuana Use in 2019 Rose in College-Age Adults

Increases are among the largest in history of national study.

Vaping marijuana and vaping nicotine rose sharply in the past three years among college-age (19-22 years old) adults, according to 2019 survey results from the Monitoring the Future (MTF) study. The percentage of college students who said they vaped marijuana in the past 30 days rose from 5.2% in 2017 to 14% in 2019.… Read full story

NIH Augments Large Scale Study of Alzheimer’s Disease Biomarkers

To meet the pressing need to better understand the prevalence, progression, and clinical impact of Alzheimer’s disease among Mexican Americans, the National Institutes of Health has added funding for more biomarker measures, including positron emission tomography (PET) imaging, to the ongoing Health and Aging Brain Among Latino Elders (HABLE) Study.… Read full story

NIH ACTIV Initiative Launches Adaptive Clinical Trials of Blood-Clotting Treatments for COVID-19

The National Institutes of Health has launched two of three adaptive Phase 3 clinical trials evaluating the safety and effectiveness of varying types of blood thinners to treat adults diagnosed with COVID-19. Part of the Accelerating COVID-19 Therapeutic Interventions and Vaccines (ACTIV) initiative, these trials will be conducted at more than 100 sites around the world and will involve patients in various clinical settings — those who have not been hospitalized, those currently hospitalized and those discharged after hospitalization for moderate to severe disease.… Read full story

Probiotic Skin Therapy Improves Eczema in Children, NIH Study Suggests

An experimental treatment for eczema that aims to modify the skin microbiome safely reduced disease severity and increased quality of life for children as young as 3 years of age, a National Institutes of Health study has found. These improvements persisted for up to eight months after treatment stopped, researchers report Sept.… Read full story